参考文献/References:
[1] Li WC,Rukstalis JM,Nishimura W,et al.Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats[J].J Cell Sci,2010,123(Pt 16):2792-2802.DOI:10.1242/jcs.065268.
[2] Téllez N,Vilaseca M,Martí Y,et al. β-Cell dedifferentiation, reduced duct cell plasticity, and impaired β-cell mass regeneration in middle-aged rats[J].Am J Physiol Endocrinol Metab,2016,311(3):E554-E563.DOI:10.1152/ajpendo.00502.2015.
[3] Ackermann Misfeldt A,Costa RH,Gannon M.Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1[J].Diabetes,2008,57(11):3069-3077.DOI:10.2337/db08-0878.
[4] Zhou JX,Dhawan S,Fu H,et al.Combined modulation of polycomb and trithorax genes rejuvenates β cell replication[J].J Clin Invest,2013,123(11):4849-4858. DOI:10.1172/JCI69468.
[5] Ju L,Wen X,Wang C,et al.Salidroside, a natural antioxidant, improves β-cell survival and function via activating AMPK pathway[J].Front Pharmacol,2017,8:749.DOI:10.3389/fphar.2017.00749.
[6] Shen W,Tremblay MS,Deshmukh VA,et al.Small-molecule inducer of β cell proliferation identified by high-throughput screening[J].J Am Chem Soc,2013,135(5):1669-1672.DOI:10.1021/ja309304m.
[7] Shen W,Taylor B,Jin Q,et al.Inhibition of DYRK1A and GSK3B induces human β-cell proliferation[J].Nat Commun,2015,6:8372.DOI:10.1038/ncomms9372.
[8] Kondegowda NG,Fenutria R,Pollack IR,et al.Osteoprotegerin and denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-κB ligand pathway[J].Cell Metab,2015,22(1):77-85.DOI:10.1016/j.cmet.2015.05.021.
[9] El Ouaamari A,Dirice E,Gedeon N,et al.SerpinB1 promotes pancreatic β cell proliferation[J].Cell Metab,2016,23(1):194-205.DOI:10.1016/j.cmet.2015.12.001.
[10] Dai C,Hang Y,Shostak A,et al.Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling[J].J Clin Invest,2017,127(10):3835-3844.DOI:10.1172/JCI91761.
[11] Téllez N,Montanya E.Gastrin induces ductal cell dedifferentiation and β-cell neogenesis after 90% pancreatectomy[J].J Endocrinol,2014,223(1):67-78.DOI:10.1530/JOE-14-0222.
[12] Donadel G, Pastore D, Della-Morte D,et al. FGF-2b and h-PL transform duct and non-endocrine human pancreatic cells into endocrine insulin secreting cells by modulating differentiating genes[J].Int J Mol Sci,2017,18(11). pii: E2234. DOI:10.3390/ijms18112234.
[13] Wu F,Guo L,Jakubowski A,et al.TNF-like weak inducer of apoptosis(TWEAK)promotes beta cell neogenesis from pancreatic ductal epithelium in adult mice[J].PLoS One,2013,8(8):e72132.DOI:10.1371/journal.pone.0072132.
[14] Ghaye AP,Bergemann D,Tarifen～o-Saldivia E,et al.Progenitor potential of nkx6.1-expressing cells throughout zebrafish life and during beta cell regeneration[J].JPBMC Biol,2015,13:70.DOI:10.1186/s12915-015-0179-4.
[15] Huang W,Beer RL,Delaspre F,et al.Sox9b is a mediator of retinoic acid signaling restricting endocrine progenitor differentiation[J].Dev Biol,2016,418(1):28-39.DOI:10.1016/j.ydbio.2016.08.019.
[16] Zhang Y,Fava GE,Wang H,et al.PAX4 gene transfer induces α-to-β cell phenotypic conversion and confers therapeutic benefits for diabetes treatment[J].Mol Ther,2016,24(2):251-260.DOI:10.1038/mt.2015.181.
[17] Baeyens L,Lemper M,Leuckx G,et al.Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice[J].Nat Biotechnol,2014,32(1):76-83.DOI:10.1038/nbt.2747.
[18] Teichenne J,Morró M,Casellas A,et al.Identification of miRNAs involved in reprogramming acinar cells into insulin producing cells[J].PLoS One,2015,10(12):e0145116.DOI:10.1371/journal.pone.0145116.
[19] Courtney M,Gjernes E,Druelle N,et al.The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells[J].PLoS Genet,2013,9(10):e1003934.DOI:10.1371/journal.pgen.1003934.
[20] Li J,Casteels T,Frogne T,et al.Artemisinins target GABAA receptor signaling and impair α cell identity[J].Cell,2017,168(1-2):86-100.e15.DOI:10.1016/j.cell.2016.11.010.
[21] Ben-Othman N,Vieira A,Courtney M,et al.Long-term GABA administration induces alpha cell-mediated beta-like cell neogenesis[J].Cell,2017,168(1-2):73-85.e11.DOI:10.1016/j.cell.2016.11.002.
[22] van der Meulen T,Lee S,Noordeloos E,et al.Artemether does not turn α cells into β cells[J].Cell Metab,2018,27(1):218-225.e4.DOI:10.1016/j.cmet.2017.10.002.
[23] Napolitano T,Avolio F,Vieira A,et al.GABA signaling stimulates α-cell-mediated β-like cell neogenesis[J].Commun Integr Biol,2017,10(3):e1300215.DOI:10.1080/19420889.2017.1300215.
[24] Al-Hasani K,Pfeifer A,Courtney M,et al.Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes[J].Dev Cell,2013,26(1):86-100.DOI:10.1016/j.devcel.2013.05.018.
[25] Matsuoka TA,Kawashima S,Miyatsuka T,et al.Mafa enables Pdx1 to effectively convert pancreatic islet progenitors and committed islet α-cells into β-cells in vivo[J].Diabetes,2017,66(5):1293-1300.DOI:10.2337/db16-0887.
[26] Tang DQ,Shun L,Koya V,et al.Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes[J].Am J Transl Res,2013,5(2):184-199.
[27] Wei R,Hong T.Lineage reprogramming: a promising road for pancreatic β cell regeneration[J].Trends Endocrinol Metab,2016,27(3):163-176.DOI:10.1016/j.tem.2016.01.002.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(04):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(04):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(04):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(04):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(04):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(04):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(04):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(04):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]